AI assistant
Revenio Group Oyj — Director's Dealing 2026
Jun 2, 2026
3236_rns_2026-06-02_4a7664e3-d007-46df-9405-b72895cc09b2.html
Director's Dealing
Open in viewerOpens in your device viewer
Revenio Group Corporation: Managers' Transactions - Marc Abitbol
Revenio Group Corporation: Managers' Transactions - Marc Abitbol
Revenio Group Corporation | Stock Exchange Release | June 02, 2026 at 10:00:00 EEST
Person subject to the notification requirement
Name: Marc Abitbol
Position: Member of the Board/Deputy member
Issuer: Revenio Group Oyj
LEI: 743700I27E0FWSXLKK04
Notification type: INITIAL NOTIFICATION
Reference number: 158933/9/8
Transaction date: 2026-06-01
Outside a trading venue
Instrument type: SHARE
ISIN: FI0009010912
Nature of transaction: SUBSCRIPTION
Transaction details (1):
Volume: 433335 Unit price: 22.4 EUR
Aggregated transactions (1):
Volume: 433335 Volume weighted average price: 22.4 EUR
For further information, please contact
CEO Jouni Toijala
+358 50 484 0085
Distribution
Nasdaq Helsinki
FIN-FSA
Key media
Revenio Group in brief
Revenio is a leading turnkey solutions provider in the global eye care market. The group offers fast, user-friendly, and reliable tools for diagnosing a wide variety of eye diseases. Revenio’s solutions include e.g. tonometers, fundus imaging devices, optical coherence tomography (OCT), perimeters, multimodal devices, refraction systems, and software solutions under iCare and Visionix.
In May 2026, Revenio joined forces with Visionix, creating the most innovative, creative and comprehensive entity serving eye care professionals across optometry, optical retail and ophthalmology. In 2025, the Group’s net sales totaled EUR 109.7 million, with an operating profit of EUR 25.4 million. Revenio Group Corporation is listed on Nasdaq Helsinki with the trading code REG1V.
Attachments: